HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation

NCT05409378 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped HLT Business Decision

Conditions

Aortic Regurgitation

Interventions

DEVICE: The HLT® Meridian® TAVR Valve (Meridian® with TriVentTM Anticalcification Treatment Valve and Pathfinder® Delivery System)

Sponsor

HLT Inc.